Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults
- PMID: 24170170
- PMCID: PMC4037144
- DOI: 10.1176/appi.ajp.2013.12121590
Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults
Abstract
Objective: The knowledge that one carries the apolipoprotein E (APOE) ε4 allele risk factor for Alzheimer's disease was recently found to have little short-term psychological risk. The authors investigated the impact of knowledge of carrying the risk allele on subjective ratings of memory and objective memory test performance of older adults.
Method: Using a nested case-control design, the authors administered objective verbal and visual memory tests and self-rating scales of memory function to 144 cognitively normal older adults (ages 52-89) with known APOE genotype who knew (ε4+, N=25; ε4-, N=49) or did not know (ε4+, N=25; ε4-, N=45) their genotype and genetic risk for Alzheimer's disease prior to neuropsychological evaluation.
Results: Significant genotype-by-disclosure interaction effects were observed on several memory rating scales and tests of immediate and delayed verbal recall. Older adults who knew their ε4+ genotype judged their memory more harshly and performed worse on an objective verbal memory test than did ε4+ adults who did not know. In contrast, older adults who knew their ε4- genotype judged their memory more positively than did ε4- adults who did not know, but these groups did not differ in objective memory test performance.
Conclusions: Informing older adults that they have an APOE genotype associated with an increased risk of Alzheimer's disease can have adverse consequences on their perception of their memory abilities and their performance on objective memory tests. The patient's knowledge of his or her genotype and risk of Alzheimer's disease should be considered when evaluating cognition in the elderly.
Figures
Comment in
-
Minding the aging brain: are we ready for personalized medicine?Am J Psychiatry. 2014 Feb;171(2):137-9. doi: 10.1176/appi.ajp.2013.13111536. Am J Psychiatry. 2014. PMID: 24500455 Free PMC article. No abstract available.
Similar articles
-
APOE ε4-Allele in Middle-Aged and Older Autistic Adults: Associations with Verbal Learning and Memory.Int J Mol Sci. 2023 Nov 5;24(21):15988. doi: 10.3390/ijms242115988. Int J Mol Sci. 2023. PMID: 37958971 Free PMC article.
-
Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.Arch Gen Psychiatry. 2005 Feb;62(2):209-16. doi: 10.1001/archpsyc.62.2.209. Arch Gen Psychiatry. 2005. PMID: 15699298
-
Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.Am J Psychiatry. 2006 Sep;163(9):1603-10. doi: 10.1176/ajp.2006.163.9.1603. Am J Psychiatry. 2006. PMID: 16946187
-
Does apolipoprotein E genotype influence cognition in middle-aged individuals?Curr Opin Neurol. 2015 Dec;28(6):612-7. doi: 10.1097/WCO.0000000000000262. Curr Opin Neurol. 2015. PMID: 26402402 Review.
-
The effect of apolipoprotein E genotype on spatial processing in humans: A meta-analysis and systematic review.Cortex. 2024 Aug;177:268-284. doi: 10.1016/j.cortex.2024.05.006. Epub 2024 May 31. Cortex. 2024. PMID: 38878339 Review.
Cited by
-
Predicting age of onset and progression of disease in late-onset genetic neurodegenerative diseases: An ethics review and research agenda.Eur J Hum Genet. 2024 Nov;32(11):1361-1370. doi: 10.1038/s41431-024-01688-7. Epub 2024 Sep 24. Eur J Hum Genet. 2024. PMID: 39317749 Review.
-
Psychosocial implications of learning amyloid PET results in an observational cohort.Alzheimers Dement. 2024 Sep;20(9):6579-6589. doi: 10.1002/alz.14153. Epub 2024 Aug 11. Alzheimers Dement. 2024. PMID: 39129396 Free PMC article.
-
Longitudinal Trajectories of the Cognitive Function Index in the A4 Study.J Prev Alzheimers Dis. 2024;11(4):838-845. doi: 10.14283/jpad.2024.125. J Prev Alzheimers Dis. 2024. PMID: 39044492 Free PMC article. Clinical Trial.
-
Schoolhouse risk: Can we mitigate the polygenic Pygmalion effect?Acta Psychol (Amst). 2024 Aug;248:104403. doi: 10.1016/j.actpsy.2024.104403. Epub 2024 Jul 14. Acta Psychol (Amst). 2024. PMID: 39003994 Free PMC article. Clinical Trial.
-
Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway.Nat Neurosci. 2024 Jul;27(7):1236-1252. doi: 10.1038/s41593-024-01669-5. Epub 2024 Jun 19. Nat Neurosci. 2024. PMID: 38898183 Review.
References
-
- Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–923. - PubMed
-
- Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43:1467–1472. - PubMed
-
- Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance MA, Schmechel DE, Saunders AM, Goldgaber D, Roses AD. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:8098–8102. - PMC - PubMed
-
- Kane RA, Kane RL. Effect of genetic testing for risk of Alzheimer’s disease. N Engl J Med. 2009;361:298–299. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
